Chlorpromazine 10mg tablets

Country: United Kingdom

Language: English

Source: MHRA (Medicines & Healthcare Products Regulatory Agency)

Active ingredient:

Chlorpromazine hydrochloride

Available from:

Special Order

ATC code:

N05AA01

INN (International Name):

Chlorpromazine hydrochloride

Dosage:

10mg

Pharmaceutical form:

Oral tablet

Class:

No Controlled Drug Status

Prescription type:

Valid as a prescribable product

Product summary:

BNF: 04020100

Patient Information leaflet


rigid or stiff muscles, trembling or shaking, difficulty moving

passing large amounts of urine, excessive thirst and having
a dry mouth or skin. You may be more likely get infections
such as thrush. This could be due to too much sugar in your
blood (hyperglycaemia)

unusual eye movements (including rolling of the eyes)

your neck becomes twisted to one side

your jaw is tight and stiff

you have difficulty in passing water (urine)

feeling tired, weak, confused and have muscles that ache,
are stiff or do not work well. This may be due to low sodium
levels in your blood.
TELL YOUR DOCTOR OR PHARMACIST IF ANY OF THE FOLLOWING SIDE
EFFECTS GETS SERIOUS OR LASTS LONGER THAN A FEW DAYS
VERY COMMON (MAY AFFECT MORE THAN 1 IN 10 PEOPLE)

Dry mouth

Feeling drowsy or sleepy

Putting on weight
COMMON (MAY AFFECT UP TO 1 IN 10 PEOPLE)

Abnormal production of breast milk in men and women

Loss of menstrual periods

Feeling anxious
NOT KNOWN (FREQUENCY CANNOT BE ESTIMATED FROM THE
AVAILABLE DATA)

Breast enlargement in men

Difficulty in getting or keeping an erection (impotence)

Reduced sexual desire in women

Difficulty sleeping (insomnia)

Feeling agitated

Being more sensitive to the sun than usual

Stuffy nose

Skin rashes

Tiredness, low mood
WITHDRAWAL EFFECTS:
If this medicine is stopped suddenly nausea, vomiting and
difficulty sleeping (insomnia), tremor (shaking), jerky body
movements and the inability to control movements of the hands
and body can occur.
If any of the side effects get serious, or if you notice any side
effects not mentioned in this leaflet, please tell your doctor or
pharmacist.
REPORTING OF SIDE EFFECTS
If you get any side effects, talk to your doctor, pharmacist or
nurse. This includes any possible side effects not listed in this
leaflet. You can also report side effects directly via the Yellow
Card Scheme at: www.mhra.gov.uk/yellowcard.
By reporting side effects you can help provide more information
on the safety of this medic

Summary of Product characteristics

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
CHLORACTIL/Chlorpromazine HC1
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 10.00mg of Chlorpromazine HC1 BP.
_Excipients with known effect_: Each tablet also contains 43.60 mg of
lactose
For the full list of excipients, see section 6.1.
3
PHARMACEUTICAL FORM
Film-Coated Tablet
White, film-coated, biconvex, odourless tablets, plain on both sides.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Schizophrenia and other psychoses (especially paranoid), mania and
hypomania. In anxiety psychomotor agitation excitement, violent or
dangerously impulsive behaviour. Is used as an adjunct in the short
term
management of these conditions.
Intractable hiccup.
Nausea and vomiting of terminal illness (where other drugs have failed
or are
not available).
Induction of hypothermia is facilitated by chloractil which prevents
shivering
causes vasodilatation.
Childhood schizophrenia and autism.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Dosages should be low to begin with and gradually increased under
close
supervision until the optimum dosage for the individual is reached.
Individuals vary considerably and the optimum dose may be affected by
the
formulation used.
Dosage of chlorpromazine in schizophrenia, other psychoses, anxiety
and
agitation etc.
Adult:
Initially 25 mg t.d.s. or 75 mg at bedtime increasing by daily amounts
of 25
mg to an effective maintenance dose. This is usually in the range 75
to 300mg
daily but some patients may require up to 1 g daily.
Children under 1 year:
Do not use unless need is life saving.
Children 1-5 years:
0.5 mg/kg body weight every 4-6 hours to a maximum recommended dose of
40mg daily.
Children 6-12 years:
1
/
3
-
1
/
2
adult dose to a maximum recommended dose of 75 mg dally.
Elderly or debiltated patients:
Start with
1
/
3
-
1
/
2
usual adult dose with a more gradual increase in dosage.
Hiccups
Adult:
25-50 mg t.d.s. or q.d.s.
Children under 1 year:
No information available.
Children 1-5 years:
No information